Breslin & Breslin, P.A.
201.546.5881
medical malpractice & personal injurySuper-Lawyers

Product Liability Archives

New safety tech promises great changes for motorists in future

A professor and traffic safety expert at one university calls the concept of accident-free cars "very hot" and says that the technology enabling them will be sufficiently advanced to allow such vehicles to begin operating on some roads and highways in the near foreseeable future.

Peanut butter recall from Salmonella outbreak

Most people have heard recent news reports regarding a Salmonella outbreak caused by peanut butter now being sold in Trader Joe's stores throughout the nation and even right here in Bergen County. The supermarket chain has ordered a voluntary recall of the tainted peanut butter as a precautionary measure.

Patron's timely intervention in New Jersey waterslide mishap noted

Crystal Springs Resort, the owner and managing operator of the Mountain Creek Waterpark in Vernon, is likely concerned with issues relating to both premises liability and product liability in the aftermath of an accident that occurred at the park in mid-summer.

Risperdal product liability outcome deemed a "landmark settlement"

Calling it a "landmark settlement," one state attorney general from among 35 other s pitted against New Jersey-based pharmaceutical giant Johnson & Johnson (J&J) lauds the recent settlement between J&J and the U.S. Food and Drug Administration (FDA), which also includes the three dozen plaintiff states.

Report: J&J settles first round of DePuy ASR hip implant suits

Multiple news sources are reporting that persons closely familiar with the Johnson & Johnson (J&J) DePuy ASR hip implant litigation say that the New Jersey-based pharmaceutical giant has reached settlements with three plaintiffs in the first product liability lawsuits slated for trial in state court.

Warning devices may not detect children in hot vehicles

According to federal data, heatstroke is the leading cause of non-accident motor vehicle deaths among children younger than 14. In 2011, more than 30 children died of heatstroke after being left in a vehicle, and 2010 saw nearly 50 such deaths.

First vaginal mesh trial ends in verdict for plaintiff

Four years after her long medical nightmare began, a woman has been awarded $5 million in her lawsuit against New Jersey-based C.R. Bard Inc., the manufacturer of the vaginal mesh device that has caused her significant pain and injury. The personal injury attorneys representing the hundreds of other injured women that have filed product liability lawsuits believe that it signals success for their clients in the pending consolidated cases against Bard, Johnson & Johnson, Boston Scientific Corp. and others, which are scheduled to go to trial early next year.

Artificial hip successor has same issues as original

About two years ago, New Jersey company Johnson & Johnson made the widely-publicized decision to recall the ASR artificial hip manufactured and sold by DePuy Orthopaedics, a unit of J&J. The company set aside $3 billion to compensate people who had filed personal injury lawsuits in connection with the defective products, and seemed to acknowledge the danger of metal-on-metal artificial hips.

Medical device labeling could lower injury risk

Last month, the U.S. Food and Drug Administration (FDA) proposed a policy which, if adopted, could significantly increase the oversight and safety of the medical device industry. Under the proposal, each individual device would receive its own identification number, allowing medical professionals and manufacturers to better track defective products, determine the cause of the problems and alert other patients who are using the same device.

J&J sets aside millions for products liability, kickbacks cases

Bergen County residents who have suffered injuries from faulty DePuy hip replacements or other defective Johnson & Johnson products will likely be interested to learn that J&J recently set aside $600 million in preparation for a potential settlement over kickbacks allegations. This is in addition to the $5.3 billion that has reportedly already been reserved for potential products liability and kickback claims in relation to other J&J medications and medical devices.